AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 290 filers reported holding AVANOS MED INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,663,961 | +9.9% | 89,575 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $2,423,900 | -37.9% | 89,575 | -50.0% | 0.01% | +12.5% |
| Q3 2022 | $3,901,944 | -21.3% | 179,150 | -1.2% | 0.01% | -11.1% |
| Q2 2022 | $4,959,055 | -35.2% | 181,350 | -20.6% | 0.01% | -18.2% |
| Q1 2022 | $7,651,700 | +87.2% | 228,400 | +93.7% | 0.01% | +10.0% |
| Q4 2021 | $4,088,000 | +0.9% | 117,900 | -9.2% | 0.01% | -9.1% |
| Q3 2021 | $4,053,000 | -57.1% | 129,900 | -50.0% | 0.01% | -21.4% |
| Q2 2021 | $9,448,000 | +637.0% | 259,800 | +786.7% | 0.01% | +250.0% |
| Q1 2021 | $1,282,000 | +11.4% | 29,300 | -15.4% | 0.00% | 0.0% |
| Q3 2020 | $1,151,000 | -53.2% | 34,636 | -58.7% | 0.00% | -20.0% |
| Q2 2020 | $2,462,000 | +9.1% | 83,800 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $2,256,000 | -10.0% | 83,800 | +12.6% | 0.01% | +20.0% |
| Q4 2019 | $2,508,000 | +4.0% | 74,400 | +15.5% | 0.01% | 0.0% |
| Q3 2019 | $2,412,000 | +1.3% | 64,400 | +17.9% | 0.01% | 0.0% |
| Q2 2019 | $2,382,000 | – | 54,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,310,272 | $63,163,000 | 4.83% |
| RGM Capital, LLC | 2,978,889 | $81,443,000 | 4.25% |
| Tributary Capital Management, LLC | 586,117 | $16,024,000 | 1.59% |
| HEARTLAND ADVISORS INC | 395,141 | $10,803,000 | 0.75% |
| Hillsdale Investment Management Inc. | 169,400 | $4,631,000 | 0.37% |
| WESTWOOD HOLDINGS GROUP INC | 1,068,905 | $29,225,000 | 0.32% |
| Keene & Associates, Inc. | 11,642 | $318,000 | 0.30% |
| Wakefield Asset Management LLLP | 24,356 | $666,000 | 0.28% |
| CORNERCAP INVESTMENT COUNSEL INC | 36,025 | $985,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 26,366 | $721,000 | 0.11% |